These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26508680)

  • 1. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.
    Higuchi T; Abe M; Yamazaki T; Mizuno M; Okawa E; Ando H; Oikawa O; Okada K; Kikuchi F; Soma M
    Nutrients; 2014 Dec; 6(12):5992-6004. PubMed ID: 25533009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
    Culleton BF; Walsh M; Klarenbach SW; Mortis G; Scott-Douglas N; Quinn RR; Tonelli M; Donnelly S; Friedrich MG; Kumar A; Mahallati H; Hemmelgarn BR; Manns BJ
    JAMA; 2007 Sep; 298(11):1291-9. PubMed ID: 17878421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial.
    Ibarra-Sifuentes HR; Del Cueto-Aguilera Á; Gallegos-Arguijo DA; Castillo-Torres SA; Vera-Pineda R; Martínez-Granados RJ; Atilano-Díaz A; Cuellar-Monterrubio JE; Pezina-Cantú CO; Martínez-Guevara EJ; Ortiz-Treviño JF; Delgado-García GR; Martínez-Jiménez JG; Cruz-Valdez J; Sánchez-Martínez C
    Ther Apher Dial; 2017 Oct; 21(5):459-464. PubMed ID: 28805348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.
    Foley RN; Curtis BM; Randell EW; Parfrey PS
    Clin J Am Soc Nephrol; 2010 May; 5(5):805-13. PubMed ID: 20378644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O; Spinar J; Tomandl J; Konecny T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
    Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .
    Akaishi M; Hiroe M; Hada Y; Suzuki M; Tsubakihara Y; Akizawa T;
    J Cardiol; 2013 Oct; 62(4):249-56. PubMed ID: 23787155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial.
    Hur E; Usta M; Toz H; Asci G; Wabel P; Kahvecioglu S; Kayikcioglu M; Demirci MS; Ozkahya M; Duman S; Ok E
    Am J Kidney Dis; 2013 Jun; 61(6):957-65. PubMed ID: 23415416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography.
    Chang ST; Chen CC; Chen CL; Cheng HW; Chung CM; Yang TY
    Blood Purif; 2004; 22(4):351-9. PubMed ID: 15297785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients　- Multi-Center Study.
    Naito J; Ohashi H; Ohno M; Sugiyama M; Hayakawa K; Kunishima A; Takada N; Kariya T; Goto K; Takatsu H; Ohira T; Nakahara K; Murata I; Minatoguchi S; Yoshida G; Okura H; Minatoguchi S
    Circ Rep; 2019 Oct; 1(11):508-516. PubMed ID: 33693093
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
    Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
    Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.